Medtronic PLC Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.Medtronic PLC (MDT) shares rose 1.64% to $92.09 on Tuesday, outperforming the broader market as the S&P 500 and Dow Jones fell. Despite this gain, Medtronic underperformed relative to some competitors; Johnson & Johnson and Abbott Laboratories saw larger gains, while Danaher declined. The stock remains 13.39% below its 52-week high of $106.33. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Medtronic PLC (MDT) rallied 1.64% to $92.09 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.
Medtronic PLC closed 13.39% short of its 52-week high of $106.33, which the company reached on November 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 3.33% to $271.11, Danaher Corp. (DHR) fell 1.51% to $199.58, and Abbott Laboratories (ABT) rose 2.09% to $112.68.
Trading volume (6.6 M) remained 1.7 million below its 50-day average volume of 8.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-18-26 1639ET